“…Two recent studies demonstrated that for PwD, COVID-19 prevention policies worsened their cognitive function (53.4%–55.1%), neuropsychiatric symptoms (NPS) (48.3%–51.9%), increased the incidence of new-onset NPS (25.9%), and caused functional decline (34.5%) (Borelli et al, 2021; Rainero et al, 2021). Previous research found that the incidence of stress in CGs increased from 9% to 22% of CGs before and during the COVID-19 pandemic (Nikolaidou et al, 2022). However, few global and local studies have focused on the effects of COVID-19 on the mental health, well-being, and health-related concerns of CGs (Cohen et al, 2020; Losada et al, 2022; Park, 2020).…”